These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30332404)

  • 61. Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression.
    Gianotti N; Marchetti G; Antinori A; Saracino A; Gori A; Rizzardini G; Lichtner M; Bandera A; Mussini C; Girardi E; dʼArminio Monforte A; Cozzi-Lepri A
    J Acquir Immune Defic Syndr; 2017 Dec; 76(4):417-422. PubMed ID: 28816721
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria.
    Aliyu MH; Blevins M; Parrish DD; Megazzini KM; Gebi UI; Muhammad MY; Ahmed ML; Hassan A; Shepherd BE; Vermund SH; Wester CW
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):e41-9. PubMed ID: 23727981
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Depression at antiretroviral therapy initiation and clinical outcomes among a cohort of Tanzanian women living with HIV.
    Sudfeld CR; Kaaya S; Gunaratna NS; Mugusi F; Fawzi WW; Aboud S; Smith Fawzi MC
    AIDS; 2017 Jan; 31(2):263-271. PubMed ID: 27835614
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.
    Calkins KL; Lesko CR; Chander G; Moore RD; Lau B
    J Acquir Immune Defic Syndr; 2018 Mar; 77(3):317-324. PubMed ID: 29210833
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality.
    Letang E; Müller MC; Ntamatungiro AJ; Kimera N; Faini D; Furrer H; Battegay M; Tanner M; Hatz C; Boulware DR; Glass TR
    Open Forum Infect Dis; 2015 Apr; 2(2):ofv046. PubMed ID: 26213690
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Food insecurity may lead to incomplete HIV viral suppression and less immune reconstitution among HIV/hepatitis C virus-coinfected people.
    Aibibula W; Cox J; Hamelin AM; Moodie E; Naimi AI; McLinden T; Klein MB; Brassard P
    HIV Med; 2018 Feb; 19(2):123-131. PubMed ID: 29094807
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Determinants of suboptimal immune recovery among a Chinese Yi ethnicity population with sustained HIV suppression.
    Chen L; Liu CH; Kang S; Du L; Ma F; Li C; Bai L; Li H; Tang H
    BMC Infect Dis; 2022 Feb; 22(1):137. PubMed ID: 35135485
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of sex and age on outcomes among HIV-2-infected patients starting antiretroviral therapy in West Africa.
    Tchounga BK; Hønge BL; Eholie SP; Coffie PA; Jespersen S; Wejse C; Dabis F; Geoffrey GS; Ekouevi DK;
    AIDS; 2016 Nov; 30(17):2707-2714. PubMed ID: 27536979
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A non-synonymous polymorphism in IL-23R Gene (rs1884444) is associated with reduced risk to schistosomiasis-associated Immune Reconstitution Inflammatory Syndrome in a Kenyan population.
    Ogola GO; Ouma C; Jura WG; Muok EO; Colebunders R; Mwinzi PN
    BMC Infect Dis; 2014 Jun; 14():316. PubMed ID: 24912586
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Weight change at 1 mo of antiretroviral therapy and its association with subsequent mortality, morbidity, and CD4 T cell reconstitution in a Tanzanian HIV-infected adult cohort.
    Sudfeld CR; Isanaka S; Mugusi FM; Aboud S; Wang M; Chalamilla GE; Giovannucci EL; Fawzi WW
    Am J Clin Nutr; 2013 Jun; 97(6):1278-87. PubMed ID: 23636235
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Magnitude and correlates of virological failure among adult HIV patients receiving PI based second line ART regimens in north western Tanzania; a case control study.
    Gunda DW; Kilonzo SB; Mtaki T; Bernard DM; Kalluvya SE; Shao ER
    BMC Infect Dis; 2019 Mar; 19(1):235. PubMed ID: 30845924
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa.
    Balestre E; Eholié SP; Lokossue A; Sow PS; Charurat M; Minga A; Drabo J; Dabis F; Ekouevi DK; Thiébaut R;
    AIDS; 2012 May; 26(8):951-7. PubMed ID: 22382142
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania.
    Mosha F; Muchunguzi V; Matee M; Sangeda RZ; Vercauteren J; Nsubuga P; Lyamuya E; Vandamme AM
    BMC Public Health; 2013 Jan; 13():38. PubMed ID: 23320567
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
    Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
    PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition.
    Mossdorf E; Stoeckle M; Mwaigomole EG; Chiweka E; Kibatala PL; Geubbels E; Urassa H; Abdulla S; Elzi L; Tanner M; Furrer H; Hatz C; Battegay M
    BMC Infect Dis; 2011 Apr; 11():98. PubMed ID: 21504595
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
    Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Compromised CD4:CD8 ratio recovery in people living with HIV aged over 50 years: an observational study.
    Francis-Morris A; Mackie NE; Eliahoo J; Ramzan F; Fidler S; Pollock KM
    HIV Med; 2020 Feb; 21(2):109-118. PubMed ID: 31617962
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HLA B*5701 status, disease progression, and response to antiretroviral therapy.
    UK Collaborative HIV Cohort Study Steering Committee
    AIDS; 2013 Oct; 27(16):2587-92. PubMed ID: 23921616
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HIV status and participation in HIV surveillance in the era of antiretroviral treatment: a study of linked population-based and clinical data in rural South Africa.
    Bärnighausen T; Tanser F; Malaza A; Herbst K; Newell ML
    Trop Med Int Health; 2012 Aug; 17(8):e103-10. PubMed ID: 22943374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.